a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China
Clinical trial NCT05546125 · COMPLETED
Trial details
- NCT number
- NCT05546125
- Sponsor
- Pfizer Pharmaceuticals Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-23
- Primary completion
- 2023-02-27
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.